Source:http://linkedlifedata.com/resource/pubmed/id/16420246
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-19
|
pubmed:abstractText |
Generalized vitiligo is a common autoimmune disorder characterized by white patches of skin and overlying hair caused by loss of pigment-forming melanocytes from involved areas. Familial clustering of vitiligo is not uncommon, and patients and their relatives are at increased risk for a specific complex of other autoimmune diseases. Compared with sporadic vitiligo, familial vitiligo is characterized by earlier disease onset and greater risk and broader repertoire of autoimmunity, suggesting a stronger genetic component, and perhaps stronger associations with specific alleles. To determine whether the major histocompatibility complex (MHC) contributes to the familial clustering of vitiligo and vitiligo-associated autoimmune/autoinflammatory diseases, we performed case-control and family-based association analyses of HLA class II-DRB1 and -DQB1 alleles and haplotypes in affected probands and their parents from 76 European-American Caucasian families with familial vitiligo. Affected probands showed a significantly increased frequency of DRB1*04-DQB1*0301 and a significantly decreased frequency of DRB1*15-DQB1*0602 compared with a large sample of reference chromosomes. Family-based association analyses confirmed these results. Probands with DRB1*04-DQB1*0301 developed vitiligo an average of 13.32 yr earlier than probands with DRB1*15-DQB1*0602. Overall, our results indicate that specific MHC-linked genetic variation contributes to risk of familial vitiligo, although HLA does not completely explain familial clustering of vitiligo-associated autoimmune/autoinflammatory diseases.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQ beta-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DQB1 antigen,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DR Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/HLA-DRB1 Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0893-5785
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16420246-Adolescent,
pubmed-meshheading:16420246-Adult,
pubmed-meshheading:16420246-Age of Onset,
pubmed-meshheading:16420246-Case-Control Studies,
pubmed-meshheading:16420246-Gene Frequency,
pubmed-meshheading:16420246-Genes, MHC Class II,
pubmed-meshheading:16420246-Genetic Predisposition to Disease,
pubmed-meshheading:16420246-HLA-DQ Antigens,
pubmed-meshheading:16420246-HLA-DQ beta-Chains,
pubmed-meshheading:16420246-HLA-DR Antigens,
pubmed-meshheading:16420246-HLA-DRB1 Chains,
pubmed-meshheading:16420246-Haplotypes,
pubmed-meshheading:16420246-Histocompatibility Antigens Class II,
pubmed-meshheading:16420246-Humans,
pubmed-meshheading:16420246-Membrane Glycoproteins,
pubmed-meshheading:16420246-Vitiligo
|
pubmed:year |
2006
|
pubmed:articleTitle |
HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.
|
pubmed:affiliation |
Human Medical Genetics Program, University of Colorado at Denver and Health Sciences Center, Aurora, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|